Modified oligonucleotides for telomerase inhibition

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/115 (2010.01) C12N 15/113 (2010.01) A61K 31/7105 (2006.01) A61P 35/00 (2006.01) C07H 21/00 (2006.01) C12N 15/11 (2006.01) C12N 9/12 (2006.01)

Patent

CA 2536015

Compounds comprising an oligonucleotide moiety covalently linked to a lipid moiety are disclosed. The oligonucleotide moiety comprises a sequence that is complementary to the RNA component of human telomerase. The compounds inhibit telomerase activity in cells with a high potency and have superior cellular uptake characteristics.

L'invention concerne des composés comprenant une fraction oligonucléotidique liée de façon covalente à une fraction lipidique. Cette fraction oligonucléotidique comprend une séquence complémentaire au composé d'ARN de la télomérase humaine. Ces composés inhibent l'activité de la télomérase dans les cellules de façon très efficacité et possèdent des caractéristiques d'absorption cellulaire supérieures.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modified oligonucleotides for telomerase inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified oligonucleotides for telomerase inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified oligonucleotides for telomerase inhibition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1721441

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.